AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.480
-0.055 (-3.58%)
Nov 3, 2026, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 1.82 billion as of November 2, 2026. It is the 19,435th most valuable company in the world and the 858th biggest in Hong Kong. Its market cap has decreased by 62.15% in one year.
Market Cap
1.82B
Enterprise Value
3.85B
Revenue
1.16B
Global Rank
Country Rank
#858 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 1.82B, a decrease of -90.99%. That is a compound annual growth rate of -44.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.82B | -53.89% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 2.47B |
| Laekna | 2.43B |
| HJ Science | 2.22B |
| HighTide Therapeutics | 2.09B |
| Antengene Corporation | 1.95B |
| Shandong Boan Biotechnology | 1.94B |
| Mabpharm | 1.77B |
| Clover Biopharmaceuticals | 1.66B |